Nearsightedness could be rising in the US, researchers concluded after comparing eyesight information for more than 4,400 people tested in 1971 and 1972 with data from another set of 8,300 people tested from 1999 to 2004.
The 1971-1972 National Health and Nutrition Examination
Survey provided the earliest nationally representative estimates
for US myopia prevalence; myopia was diagnosed by an algorithm
using either lensometry, pinhole visual acuity, and presenting
visual acuity (for presenting visual acuity 20/40) or retinoscopy
(for presenting visual acuity 20/50).
Using a similar method
for diagnosing myopia, we examined data from the 1999-2004 National
Health and Nutrition Examination Survey to determine whether
myopia prevalence had changed during the 30 years between the
2 surveys, researchers said in their findings published in the Archives of Opthalmology.
When using similar methods for each period,
the prevalence of myopia in the United States appears to be
substantially higher in 1999-2004 than 30 years earlier. Although myopia can be treated relatively easily with corrective
lenses, it engenders substantial expenditures on a population
basis owing to its high prevalence. If 25% of those aged 12
to 54 years had myopia, the associated annual cost would be
more than $2 billion; an increase in prevalence to 37%
would increase the cost to more than $3 billion. The question
of whether myopia prevalence is increasing is therefore important
to health planners and policy makers.
Identifying
modifiable risk factors for myopia could lead to the development
of cost-effective interventional strategies, the paper said.